Abuogi Lisa, Hampanda Karen, Odwar Tobias, Helova Anna, Odeny Thomas, Onono Maricianah, Bukusi Elizabeth, Turan Janet
Department of Pediatrics, University of Colorado Denver, Aurora, CO, USA.
Department of Community and Behavioral Health, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA.
AIDS Care. 2020 Jul;32(7):858-868. doi: 10.1080/09540121.2019.1659915. Epub 2019 Sep 5.
Disclosure of HIV status to sexual partners in the context of prevention of mother-to-child transmission (PMTCT) may contribute to improved PMTCT outcomes. We administered a questionnaire to 200 women with HIV enrolled in a PMTCT study during pregnancy at 12 months after birth in Western Kenya between May-September 2017. Descriptive analysis of disclosure patterns and multivariate analysis of factors associated with male partner reactions is presented. Among 180 (90%) women who reported having a male partner, 95.5% reported disclosing their HIV status to that partner. The majority of women (82.8%) reported disclosure occurred within one year of their diagnosis, with 62.7% occurring within one week. The most common forms of disclosure were: self-disclosure (55.4%), during couple's HIV testing and counseling (CHTC) (31.5%), or at an antenatal care visit (7.7%). Most women (87.5%) reported that male partner reactions to their HIV status disclosure were positive. Those with negative reactions reported their partners were confused, annoyed, or threatened to leave, however there were no reports of intimate partner violence (IPV) or break ups. Disclosure via CHTC was associated with a positive male partner reaction compared to self-disclosure (adjusted OR (aOR) 20.2, 95% Confidence Interval (CI) 1.8-221.4). Those in concordant HIV status partnerships were more likely to have a positive reaction (aOR. 6.7, 95% CI 1.7-26.6). Women experiencing frequent verbal IPV were less likely to report a positive response (aOR 0.21, 95%CI 0.1-0.8). Most postpartum women with HIV in this cohort had disclosed to their male partners early after diagnosis and experienced a positive reaction. However, a minority had still not disclosed by 12 months after the birth and some experienced negative reactions to disclosure. The form of status disclosure and impact of intimate partner violence should be given greater attention within the context of PMTCT.
在预防母婴传播(PMTCT)的背景下,向性伴侣披露艾滋病毒感染状况可能有助于改善预防母婴传播的效果。2017年5月至9月期间,我们在肯尼亚西部对200名孕期参与预防母婴传播研究的感染艾滋病毒的女性在产后12个月时进行了问卷调查。本文呈现了披露模式的描述性分析以及与男性伴侣反应相关因素的多变量分析。在报告有男性伴侣的180名(90%)女性中,95.5%的女性报告已向伴侣披露自己的艾滋病毒感染状况。大多数女性(按82.8%计算)报告在确诊后一年内进行了披露,其中62.7%是在一周内披露的。最常见的披露形式为:自行披露(55.4%)、在夫妻艾滋病毒检测与咨询(CHTC)期间(31.5%)或在产前检查时(7.7%)。大多数女性(87.5%)报告男性伴侣对她们披露艾滋病毒感染状况的反应是积极的。那些反应消极的女性报告称其伴侣感到困惑、恼怒或威胁要离开,不过没有关于亲密伴侣暴力(IPV)或分手的报告。与自行披露相比,通过夫妻艾滋病毒检测与咨询进行披露与男性伴侣的积极反应相关(调整后的比值比(aOR)为20.2,95%置信区间(CI)为1.8 - 221.4)。处于艾滋病毒感染状况一致的伴侣关系中的女性更有可能有积极反应(aOR为6.7,95%CI为1.7 - 26.6)。经常遭受言语性亲密伴侣暴力的女性报告积极反应的可能性较小(aOR为0.21,95%CI为0.1 - 0.8)。该队列中的大多数感染艾滋病毒的产后女性在确诊后不久就向其男性伴侣进行了披露,并得到了积极反应。然而,少数女性在产后12个月时仍未披露,一些女性在披露时经历了消极反应。在预防母婴传播的背景下,应更加关注感染状况披露的形式以及亲密伴侣暴力的影响。